RUA Life Sciences plc (FRA:AOHA)

Revenue by Product

Financials in millions GBX. Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Contract Manufacture	1.68M
Contract Manufacture Growth	3.32%
Biomaterials	496.00K
Biomaterials Growth	-10.47%
Vascular	16.00K

Revenue by Geography

Financials in millions GBX. Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
United States	1.95M
United States Growth	-0.21%
Switzerland	158.00K
Switzerland Growth	-5.95%
Israel	50.00K
Israel Growth	4.17%
Italy	38.00K
Italy Growth	153.33%